We recently identified ANGPTL2 as a key mediator of chronic inflammation and associated diseases, such as obesity-related metabolic syndrome19, cardiovascular disease20, 21, some autoimmune diseases22, 23, carcinogenesis24, 25 and tumor metastasis15, 26. Here, ANGPTL2 is linked to neoplasm.